Final Program in it's entirety - MyGirlsBlood

Recommendations

Info

Posters, Sunday and Monday Index of Poster Presenters cont’d 14P07 Risk Sharing: Cost Comparison of Activated Prothrombin Complex Concentrate (APCC) and Recombinant Factor VIIa (rFVIIa) for Hemophilia Patients with Inhibitors Undergoing Major Orthopaedic Surgeries Bonnet P, Epstein J, Li-McLeod J Medical Outcomes Research and Economics, Baxter BioScience, Westlake Village, CA, U.S.A. 14P08 Patient and Caregiver Preferences for Hemophilia A Treatments Mohamed A1 , Johnson F1 , Epstein J2 , Li-McLeod J2 1RTI Health Solutions, Research Triangle Park, NC, U.S.A., 2Baxter BioScience, Westlake Village, CA, U.S.A. 14P09 Healthcare Resource Utilization among Hemophilia A Patients with Inhibitor Status in the U.S. Tarantino M2 , Pipe S3 , Ye X4 , Xiong Y4 , Luo M4 , Valentino L1 1Rush University Medical Center, Chicago, IL, U.S.A., 2University of Illinois, College of Medicine-Peoria, Peoria, IL, U.S.A., 3University of Michigan, Ann Arbor, MI, U.S.A., 4Baxter Bioscience, Deerfield, IL, U.S.A. 14P10 Stability and Predictability of Treatment Cost among Non- Inhibitor Hemophilia Patients in the U.S. Pipe S1 , Tarantino M2 , Valentino L3 , Ye X4 , Xiong Y4 , Luo M4 1 2 University of Michigan, Ann Arbor, MI, University of Illinois College of Medicine-Peoria, Peoria, IL, 3Rush University Medical Center, Chicago, IL, Baxter Bioscience, Deerfield, IL, U.S.A. 14P11 Cost-Effectiveness Analysis of Primary Prophylaxis Versus On-Demand Treatment for Individuals with Severe Hemophilia Based on the Joint Outcome Study Matthew P1 , Boer R2 , Lalla A3 , Preblick R4 , Pocoski J5 1 2 University of New Mexico, New Mexico, U.S.A., Cerner LifeSciences, California, U.S.A., 3Cerner LifeSciences, California, U.S.A., 4Bayer Healthcare Pharmaceuticals, New Jersey, U.S.A., 5Bayer Healthcare Pharmaceuticals, New Jersey, U.S.A. 14P12 The Evolution Between 2001 and 2010 in the Costs of Resolving a Mild to Moderate Bleeding Episode with pdaPCC versus rFVIIa in the U.K. when Initiated Outside Hospital Riley P, Ashley D Novo Nordisk Limited, Crawley, U.K. 60 14P13 Economic Comparison of Recombinant Activated Factor VII Versus Plasma-Derived Activated Prothrombin Complex Concentrate Using the Hemophilia Registries of the Czech Republic Salaj P 1 , Penka M 2 , Smejkal P 2 , Geierova V 1 , Ovesna P 3 , Dusek L 3 1 Institute of Haematology and Blood Transfusion, 2 Department of Clinical Hematology at Faculty Hospital Brno, 3 Institute of Biostatistics and Analyses at Masaryk University in Brno, Prague, Czech Republic 14P14 Medical Cost Savings Associated with a Reduced Need for Re-Treatment and Fewer Infusions Required per Bleed in the Management of On-Demand Bleeds in Hemophilia Patients with Inhibitors Kowal S, Munakata J, Weatherall J1 , Lee W 1 2 3 4 IMS Health, IMS Health, Novo Nordisk, IMS Health 1 2 IMS Health, Falls Church, VA, U.S.A., Novo Nordisk A/S, Søborg, Denmark 14P15 The Economic Consequences of Ineffective In-Patient On- Demand Treatment for Hemophilia with Inhibitors Pokras SM1 , Weatherall J2 , Petrilla AA1 , Lee WC1 1 2 IMS Health, Falls Church, VA, U.S.A., Novo Nordisk A/S, Søborg, Denmark 14P16 A Comparison of School and Employment vs. Functional Ability: Hemophilia Patients in Peru and the U.S.A. Zappa S1 , Anderson A2 , Loayza N3 , Kuebler E4 1Cook Children’s Medical Center, Fort Worth, TX U.S.A., 2 3 Dallas Children’s, Dallas, TX U.S.A., Hospital Dos de Mayo, Lima Peru, 4Gulf States Hemophilia & Thrombophilia Center, Houston, TX U.S.A. 14P17 Health Care Utilization and Cost in Persons with Factor VIII Deficiency: Results of the Hugs VA Study Zhou Z-Y1 , Johnson K1 , Riske B2 , Ullman M3 , Baker J4 , Koerper M5 , Forsberg A6 , Miller B7 , Shapiro A8 , Huszti H9 1 2 University of Southern California, CA, U.S.A., University of Colorado Denver, CO, U.S.A., 3University of Texas Health Science at Houston, TX, U.S.A., 4University of California, Los Angeles, CA, U.S.A., 5University of California, San Francisco, CA, U.S.A., 6New England Hemophilia Center, Worcester, MA, U.S.A., 7Children’s Hospital Los Angeles/USC, Los Angeles, CA, U.S.A., 8Indiana Hemophilia & Thrombosis Center, Indianapolis, IN, U.S.A., 9Children’s Hospital Orange County, CA, U.S.A.
Index of Poster Presenters cont’d HEMOPHILIA PROGRAMS AND ORGANIZATIONS 15P02 Transitioning to Adulthood with a Bleeding Disorder Cecchini C1 , Purves E2 , Brownlow M1 1 2 Canadian Hemophilia Society, Montreal, QC, Canada, BC Children’s Hospital, Vancouver, BC, Canada 15P03 The French Haemophilia Molecular Laboratory Network: Five Years’ Experience Costa C, Vinciguerra C Laboratoire de Genetique Moleculaire, Creteil, France 15P04 An Individual Communication Strategy from a National Hemophilia Society Duffy A, Noone D 1Irish Haemophilia Society, Dublin, Ireland 15P05 Hemophilia in Morocco: Current State and Prospects El Khorassani M, Kababri M, Hessissen L, Khattab M, Kili A The Treatment Center of Hemophilia, Hematology and Pediatric Oncology Unit, Hospital of Rabat, CHU, Morocco 15P06 Education and Integration of the Entire Family into Programmes Greene D and Activities: The Irish Experience Irish Haemophilia Society, Dublin, Ireland 15P07 Volunteering for All – The Power of Volunteering of Person with Hemophilia Hu C, Wu Y, Lo C Hemophilia Association of Taiwan, Republic of China 15P08 A Review of Services and the Needs of the Bleeding Disorder Community in New Zealand Lauzon C Haemophilia Foundation of New Zealand, Canterbury, New Zealand 15P09 The Importance of the World Federation of Hemophilia’s Centre Twinning Program for the Improvement of Haemophilia Care in Serbia Mikovic D, Rakic L, Jankovic G Haemostasis Department and Haemophilia Centre, Blood Transfusion Institute of Serbia, Belgrade, Serbia 15P10 Using Consumer Input to Develop Relevant Bleeding Disorder Resources O’Callaghan S, Caris S Haemophilia Foundation Australia, Glen Iris, Victoria, Australia 15P11 Combined Programme for the Global Care of People with Hemophilia: A Desire of Collaboration and Shared Responsibility Parra R1 , Ragull O2 , Cabré P2 1 2 Haemophilia Unit Hospital Vall D’Hebron, and Catalan Association of Haemophilia, Barcelona, Spain 15P12 An Evidence-Based Approach to Management of a Multi- Chapter Nation Hemophilia Organization Tabatabaey A1,2 , Seyed Mojtaba MB2 , Ghodousi MS2 , Karami S3 1 2 Iranian Hemophilia Society; Mashhad University of Medical Sciences, 3Islamic Azad University of Mobarakeh, Iran 15P13 An Important Step in Comprehensive Care for Hemophilia in China: Phase I NNFH-China Project Wang XF1 , Ding QL1 , Zhao YQ2 , Yang RC3 , Wu JS4 , Sun J4 , Zhang XS5 , Chu YG1 Cai HY1 , Suanne B1 , Wang HL1 1 2 Shanghai Ruijin Hospital, Peking Union Medical College Hospital, 3Tianjin Hematology Hospital, 4Anhui Provincial Hospital, 5Shangdong Blood Center, Republic of China 15P14 Hemophilia Care China: A Giant Step in Development by a First Phase China/Novo Nordisk Foundation Project Wang X1 , Zhao Y2 , Yang R3 , Wu J4 , Sun J5 , Zhang X6 1 2 3 Shanghai Ruijin Hospital, Peking Union Hospital, China Institute of Hematology and Blood Disease Hospital, 4Anhui 5 Provincial Hospital, Guangzhou Nanfang Hospital, 6Shandong Blood Center, Republic of China 15P15 Pakistan Bait-ul-Mal, HPWS Collaboration for Hemophila Care: A Unique Social Welfare Partnership Zafar T2 , Ehsan Y2 , Ikram N2,3,1 1Islamabad Medical & Dental College, Islamabad, Pakistan, 2Pakistan Haemophilia Patients Welfare Society, Islamabad, Pakistan, 3Rawalpindi Medical College, Rawalpindi, Pakistan 61 Posters, Sunday and Monday
Page 1 and 2: Hemophilia Saturday, July 10 - Wedn
Page 3 and 4: Pre-Congress Sessions cont’d 10:3
Page 5 and 6: Pre-Congress Sessions cont’d 15:0
Page 7 and 8: Congress Sessions cont’d S1.6 - M
Page 9 and 10: Congress Sessions cont’d S2.5 - M
Page 11 and 12: Congress Sessions cont’d n Long T
Page 13 and 14: Congress Sessions cont’d M2.4 - M
Page 15 and 16: Congress Sessions cont’d Tuesday,
Page 17 and 18: Congress Sessions cont’d 14:15 -
Page 19 and 20: Congress Sessions cont’d T3.4 - M
Page 21 and 22: Congress Sessions cont’d n Inhibi
Page 23 and 24: Congress Sessions cont’d W2.4 - L
Page 25 and 26: Index of Speakers cont’d Halimeh,
Page 27 and 28: Index of Poster Presenters Sunday a
Page 29 and 30: Index of Poster Presenters cont’d
Page 45: Index of Poster Presenters cont’d

Final Program in it's entirety - MyGirlsBlood

Create successful ePaper yourself

Delete template?

Save as template?